Literature DB >> 10836796

A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains.

C X Chen1, D S Cho, Q Wang, F Lai, K C Carter, K Nishikura.   

Abstract

Members of the double-stranded RNA- (dsRNA) specific adenosine deaminase gene family convert adenosine residues into inosines in dsRNA and are involved in A-to-I RNA editing of transcripts of glutamate receptor (GluR) subunits and serotonin receptor subtype 2C (5-HT(2C)R). We have isolated hADAR3, the third member of this class of human enzyme and investigated its editing site selectivity using in vitro RNA editing assay systems. As originally reported for rat ADAR3 or RED2, purified ADAR3 proteins could not edit GluR-B RNA at the "Q/R" site, the "R/G" site, and the intronic "hot spot" site. In addition, ADAR3 did not edit any of five sites discovered recently within the intracellular loop II region of 5-HT(2C)R RNAs, confirming its total lack of editing activity for currently known substrate RNAs. Filter-binding analyses revealed that ADAR3 is capable of binding not only to dsRNA but also to single-stranded RNA (ssRNA). Deletion mutagenesis identified a region rich in arginine residues located in the N-terminus that is responsible for binding of ADAR3 to ssRNA. The presence of this ssRNA-binding domain as well as its expression in restricted brain regions and postmitotic neurons make ADAR3 distinct from the other two ADAR gene family members, editing competent ADAR1 and ADAR2. ADAR3 inhibited in vitro the activities of RNA editing enzymes of the ADAR gene family, raising the possibility of a regulatory role in RNA editing.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10836796      PMCID: PMC1369955          DOI: 10.1017/s1355838200000170

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  41 in total

1.  RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity.

Authors:  C M Niswender; S C Copeland; K Herrick-Davis; R B Emeson; E Sanders-Bush
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

2.  Regional differences in the extent of RNA editing of the glutamate receptor subunits GluR2 and GluR6 in rat brain.

Authors:  W Paschen; B Djuricic
Journal:  J Neurosci Methods       Date:  1995-01       Impact factor: 2.390

3.  Purification and characterization of double-stranded RNA adenosine deaminase from bovine nuclear extracts.

Authors:  U Kim; T L Garner; T Sanford; D Speicher; J M Murray; K Nishikura
Journal:  J Biol Chem       Date:  1994-05-06       Impact factor: 5.157

4.  Control of kinetic properties of AMPA receptor channels by nuclear RNA editing.

Authors:  H Lomeli; J Mosbacher; T Melcher; T Höger; J R Geiger; T Kuner; H Monyer; M Higuchi; A Bach; P H Seeburg
Journal:  Science       Date:  1994-12-09       Impact factor: 47.728

5.  Messenger RNA editing of the human serotonin 5-HT2C receptor.

Authors:  L W Fitzgerald; G Iyer; D S Conklin; C M Krause; A Marshall; J P Patterson; D P Tran; G J Jonak; P R Hartig
Journal:  Neuropsychopharmacology       Date:  1999-08       Impact factor: 7.853

6.  The cytoplasm of Xenopus oocytes contains a factor that protects double-stranded RNA from adenosine-to-inosine modification.

Authors:  L Saccomanno; B L Bass
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

7.  Tad1p, a yeast tRNA-specific adenosine deaminase, is related to the mammalian pre-mRNA editing enzymes ADAR1 and ADAR2.

Authors:  A Gerber; H Grosjean; T Melcher; W Keller
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

8.  Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing.

Authors:  U Kim; Y Wang; T Sanford; Y Zeng; K Nishikura
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

9.  Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase.

Authors:  M A O'Connell; S Krause; M Higuchi; J J Hsuan; N F Totty; A Jenny; W Keller
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

10.  Differential RNA editing efficiency of AMPA receptor subunit GluR-2 in human brain.

Authors:  S L Nutt; R K Kamboj
Journal:  Neuroreport       Date:  1994-08-15       Impact factor: 1.837

View more
  206 in total

Review 1.  Imprinted expression of small nucleolar RNAs in brain: time for RNomics.

Authors:  W Filipowicz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  Mechanism of the gBP21-mediated RNA/RNA annealing reaction: matchmaking and charge reduction.

Authors:  Ulrich F Müller; H Ulrich Göringer
Journal:  Nucleic Acids Res       Date:  2002-01-15       Impact factor: 16.971

3.  The human but not the Xenopus RNA-editing enzyme ADAR1 has an atypical nuclear localization signal and displays the characteristics of a shuttling protein.

Authors:  C R Eckmann; A Neunteufl; L Pfaffstetter; M F Jantsch
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

Review 4.  Small nucleolar RNAs: versatile trans-acting molecules of ancient evolutionary origin.

Authors:  Michael P Terns; Rebecca M Terns
Journal:  Gene Expr       Date:  2002

Review 5.  The challenge of target sequence specificity in C-->U RNA editing.

Authors:  Nicholas O Davidson
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

6.  Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2.

Authors:  Geetha C Jayan; John L Casey
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 7.  RNA editing by adenosine deaminases that act on RNA.

Authors:  Brenda L Bass
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

8.  Nucleocytoplasmic distribution of human RNA-editing enzyme ADAR1 is modulated by double-stranded RNA-binding domains, a leucine-rich export signal, and a putative dimerization domain.

Authors:  Alexander Strehblow; Martina Hallegger; Michael F Jantsch
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

9.  A comprehensive analysis of allelic methylation status of CpG islands on human chromosome 21q.

Authors:  Yoichi Yamada; Hidemi Watanabe; Fumihito Miura; Hidenobu Soejima; Michiko Uchiyama; Tsuyoshi Iwasaka; Tsunehiro Mukai; Yoshiyuki Sakaki; Takashi Ito
Journal:  Genome Res       Date:  2004-02       Impact factor: 9.043

Review 10.  Activity regulation of adenosine deaminases acting on RNA (ADARs).

Authors:  Cesare Orlandi; Alessandro Barbon; Sergio Barlati
Journal:  Mol Neurobiol       Date:  2011-11-20       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.